| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear protein-containing complex | ANAPC10 WDR36 POLR2B DDX42 NR5A2 NVL RAD9B U2AF2 MAFB BRCC3 SMG5 LSM2 RFX5 NR1H4 PHC2 MAF | 6.55e-05 | 1377 | 81 | 16 | GO:0140513 |
| Domain | Maf_N | 3.28e-10 | 4 | 81 | 4 | PF08383 | |
| Domain | Maf_TF_N | 3.28e-10 | 4 | 81 | 4 | IPR013592 | |
| Domain | Transciption_factor_Maf_fam | 1.14e-08 | 7 | 81 | 4 | IPR024874 | |
| Domain | bZIP_Maf | 2.28e-07 | 13 | 81 | 4 | IPR004826 | |
| Domain | bZIP_Maf | 2.28e-07 | 13 | 81 | 4 | PF03131 | |
| Domain | - | 5.74e-07 | 16 | 81 | 4 | 1.10.880.10 | |
| Domain | TF_DNA-bd | 1.94e-05 | 37 | 81 | 4 | IPR008917 | |
| Domain | BRLZ | 7.59e-05 | 52 | 81 | 4 | SM00338 | |
| Domain | BZIP | 8.18e-05 | 53 | 81 | 4 | PS50217 | |
| Domain | BZIP_BASIC | 8.18e-05 | 53 | 81 | 4 | PS00036 | |
| Domain | bZIP | 8.80e-05 | 54 | 81 | 4 | IPR004827 | |
| Domain | Guanine_nucleotide-bd_bsu | 1.84e-04 | 5 | 81 | 2 | IPR016346 | |
| Domain | WD40_repeat_dom | 3.05e-04 | 297 | 81 | 7 | IPR017986 | |
| Domain | - | 6.04e-04 | 333 | 81 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 6.26e-04 | 335 | 81 | 7 | IPR015943 | |
| Domain | SAM_DOMAIN | 7.75e-04 | 95 | 81 | 4 | PS50105 | |
| Domain | Gprotein_B | 8.17e-04 | 10 | 81 | 2 | IPR001632 | |
| Domain | SAM | 8.38e-04 | 97 | 81 | 4 | IPR001660 | |
| Domain | WD40 | 9.14e-04 | 259 | 81 | 6 | PF00400 | |
| Domain | WD40 | 1.09e-03 | 268 | 81 | 6 | SM00320 | |
| Domain | - | 1.17e-03 | 106 | 81 | 4 | 1.10.150.50 | |
| Domain | WD40_repeat | 1.18e-03 | 272 | 81 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.31e-03 | 278 | 81 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.34e-03 | 279 | 81 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.34e-03 | 279 | 81 | 6 | PS50294 | |
| Domain | VitD_rcpt | 1.63e-03 | 14 | 81 | 2 | IPR000324 | |
| Domain | SAM/pointed | 1.68e-03 | 117 | 81 | 4 | IPR013761 | |
| Domain | SAM_1 | 3.22e-03 | 68 | 81 | 3 | PF00536 | |
| Domain | WD40_repeat_CS | 5.64e-03 | 164 | 81 | 4 | IPR019775 | |
| Pubmed | Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. | 6.69e-08 | 4 | 90 | 3 | 28933784 | |
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 12917329 | ||
| Pubmed | 2.43e-07 | 21 | 90 | 4 | 29324782 | ||
| Pubmed | Role of large MAF transcription factors in the mouse endocrine pancreas. | 3.33e-07 | 6 | 90 | 3 | 25912440 | |
| Pubmed | Neither MafA/L-Maf nor MafB is essential for lens development in mice. | 5.82e-07 | 7 | 90 | 3 | 19624757 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | ESYT2 ANAPC10 GTF3C1 RADX POLR2B ASPM U2AF2 DHX57 BRCC3 DNAJC7 LACTB | 1.31e-06 | 670 | 90 | 11 | 22990118 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MRPS31 ESYT2 WDR36 WIZ EXD2 POLR2B UBR4 DTL U2AF2 DHX57 GNB4 RMND1 DBT GNB1 DNAJC7 LACTB | 1.34e-06 | 1496 | 90 | 16 | 32877691 |
| Pubmed | Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse. | 1.39e-06 | 9 | 90 | 3 | 22120711 | |
| Pubmed | Regulation of lens fiber cell differentiation by transcription factor c-Maf. | 1.98e-06 | 10 | 90 | 3 | 10383433 | |
| Pubmed | A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. | 3.62e-06 | 12 | 90 | 3 | 16580660 | |
| Pubmed | Two distinct origins for Leydig cell progenitors in the fetal testis. | 5.97e-06 | 14 | 90 | 3 | 21255566 | |
| Pubmed | Epidermal differentiation gene regulatory networks controlled by MAF and MAFB. | 6.62e-06 | 2 | 90 | 2 | 27097296 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 12456679 | ||
| Pubmed | Large Maf transcription factor family is a major regulator of fast type IIb myofiber determination. | 6.62e-06 | 2 | 90 | 2 | 36952339 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15249232 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22296850 | ||
| Pubmed | MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. | 6.62e-06 | 2 | 90 | 2 | 19892988 | |
| Pubmed | Generation and characterization of MafA-Kusabira Orange mice. | 6.62e-06 | 2 | 90 | 2 | 25273397 | |
| Pubmed | MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity. | 6.62e-06 | 2 | 90 | 2 | 33312178 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32764399 | ||
| Pubmed | Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. | 6.62e-06 | 2 | 90 | 2 | 20483916 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20060689 | ||
| Pubmed | Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. | 6.62e-06 | 2 | 90 | 2 | 12011435 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25763640 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18515495 | ||
| Pubmed | MafB Maintains β-Cell Identity under MafA-Deficient Conditions. | 6.62e-06 | 2 | 90 | 2 | 35862726 | |
| Pubmed | Differential expression patterns of MafB and c-Maf in macrophages in vivo and in vitro. | 6.62e-06 | 2 | 90 | 2 | 26996125 | |
| Pubmed | 1.02e-05 | 533 | 90 | 9 | 25544563 | ||
| Pubmed | 1.33e-05 | 18 | 90 | 3 | 17360442 | ||
| Pubmed | MafA is critical for maintenance of the mature beta cell phenotype in mice. | 1.98e-05 | 3 | 90 | 2 | 25500951 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 11030332 | ||
| Pubmed | Loss of MafA and MafB expression promotes islet inflammation. | 1.98e-05 | 3 | 90 | 2 | 31235823 | |
| Pubmed | MafB promotes atherosclerosis by inhibiting foam-cell apoptosis. | 1.98e-05 | 3 | 90 | 2 | 24445679 | |
| Pubmed | The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice. | 1.98e-05 | 3 | 90 | 2 | 17289919 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ESYT2 ANAPC10 GTF3C1 MAP1S RADX EXD2 POLR2B UBR4 DTL GNB4 BRCC3 GNB1 DNAJC7 | 2.10e-05 | 1257 | 90 | 13 | 37317656 |
| Pubmed | ATP6V0A1 WIZ MAP1S UBR4 MKLN1 SENP6 BRCC3 SMG5 ZNF83 MERTK GNB1 DNAJC7 RFX5 | 2.64e-05 | 1285 | 90 | 13 | 35914814 | |
| Pubmed | 2.72e-05 | 335 | 90 | 7 | 15741177 | ||
| Pubmed | MRPS31 ESYT2 ATP6V0A1 WDR36 UNC5B POLR2B UBR4 DDX42 ASPM NVL DBT DNAJC7 LACTB DMXL1 | 2.77e-05 | 1487 | 90 | 14 | 33957083 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF106 ESYT2 ANAPC10 WDR36 WIZ GTF3C1 POLR2B DDX42 U2AF2 BRCC3 LSM2 RFX5 PHC2 | 2.83e-05 | 1294 | 90 | 13 | 30804502 |
| Pubmed | 3.15e-05 | 615 | 90 | 9 | 31048545 | ||
| Pubmed | 3.70e-05 | 25 | 90 | 3 | 25918232 | ||
| Pubmed | MRPS31 ANAPC10 GTF3C1 TFB1M EXD2 POLR2B U2AF2 DHX57 BRCC3 LSM2 DBT DNAJC7 LACTB | 3.91e-05 | 1335 | 90 | 13 | 29229926 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 14680841 | ||
| Pubmed | SMS regulates the expression and function of P-gp and MRP2 in Caco-2 cells. | 3.96e-05 | 4 | 90 | 2 | 27394416 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 1543505 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 26292095 | ||
| Pubmed | The role of G protein beta subunits in the release of ATP from human erythrocytes. | 3.96e-05 | 4 | 90 | 2 | 12512701 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 17901057 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 32452758 | ||
| Pubmed | Elevated copper impairs hepatic nuclear receptor function in Wilson's disease. | 3.96e-05 | 4 | 90 | 2 | 26241054 | |
| Pubmed | 5.22e-05 | 253 | 90 | 6 | 29911972 | ||
| Pubmed | 5.24e-05 | 28 | 90 | 3 | 26554594 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 6.33e-05 | 262 | 90 | 6 | 36880596 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 11294873 | ||
| Pubmed | Inactivation of specific β cell transcription factors in type 2 diabetes. | 6.59e-05 | 5 | 90 | 2 | 23863625 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 12941695 | ||
| Pubmed | MRPS31 ZNF462 WIZ GTF3C1 NFATC3 RADX RC3H1 UBR4 GNB4 SMG5 DBT DNAJC7 RFX5 | 7.80e-05 | 1429 | 90 | 13 | 35140242 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 9.69e-05 | 410 | 90 | 7 | 26949251 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 16371464 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 18541031 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 33897412 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 16884933 | ||
| Pubmed | The Bach Family of Transcription Factors: A Comprehensive Review. | 9.87e-05 | 6 | 90 | 2 | 27052415 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 32929029 | ||
| Pubmed | 1.12e-04 | 36 | 90 | 3 | 35379950 | ||
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 17895379 | ||
| Pubmed | MafB Is Important for Pancreatic β-Cell Maintenance under a MafA-Deficient Condition. | 1.38e-04 | 7 | 90 | 2 | 31208980 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 10570481 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.67e-04 | 313 | 90 | 6 | 38270169 | |
| Pubmed | 1.80e-04 | 606 | 90 | 8 | 36538041 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 2328987 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 11279518 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 11036080 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.84e-04 | 608 | 90 | 8 | 36089195 | |
| Pubmed | MRPS31 ANAPC10 WDR36 GTF3C1 POLR2B ASPM U2AF2 DHX57 LSM2 DNAJC7 | 2.09e-04 | 971 | 90 | 10 | 33306668 | |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 10339615 | ||
| Pubmed | MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation. | 2.36e-04 | 9 | 90 | 2 | 36928411 | |
| Pubmed | 2.36e-04 | 9 | 90 | 2 | 20025861 | ||
| Pubmed | The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. | 2.75e-04 | 220 | 90 | 5 | 31822558 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 31231191 | ||
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 28705881 | ||
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 38958700 | ||
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 2.94e-04 | 10 | 90 | 2 | 28334111 | |
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 9733924 | ||
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 3.01e-04 | 50 | 90 | 3 | 24769233 | |
| Pubmed | 3.05e-04 | 225 | 90 | 5 | 12168954 | ||
| Pubmed | 3.10e-04 | 496 | 90 | 7 | 31343991 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.14e-04 | 497 | 90 | 7 | 36774506 | |
| Pubmed | MRPS31 GTF3C1 UBR4 MAFA DTL DDX42 ASPM U2AF2 DHX57 ABCC2 GNB1 DNAJC7 | 3.40e-04 | 1442 | 90 | 12 | 35575683 | |
| Pubmed | 3.51e-04 | 847 | 90 | 9 | 35850772 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 16912278 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 20138042 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 10644457 | ||
| Pubmed | 3.59e-04 | 11 | 90 | 2 | 34932372 | ||
| Pubmed | A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. | 3.59e-04 | 11 | 90 | 2 | 25982117 | |
| Pubmed | 3.71e-04 | 130 | 90 | 4 | 19386638 | ||
| Pubmed | 3.88e-04 | 515 | 90 | 7 | 31617661 | ||
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 34342229 | ||
| Pubmed | Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. | 4.30e-04 | 12 | 90 | 2 | 20186915 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 20038947 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE17 SPDYE10 SPDYE13 SPDYE15 SPDYE8 SPDYE9 SPDYE12 SPDYE14 | 4.32e-09 | 271 | 92 | 9 | chr7q11 |
| Cytoband | 7q11.23 | 4.54e-05 | 97 | 92 | 4 | 7q11.23 | |
| Cytoband | 12q24.11 | 2.01e-03 | 33 | 92 | 2 | 12q24.11 | |
| GeneFamily | Basic leucine zipper proteins | 2.85e-05 | 49 | 65 | 4 | 506 | |
| GeneFamily | Sterile alpha motif domain containing | 2.83e-04 | 88 | 65 | 4 | 760 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 8.21e-04 | 12 | 65 | 2 | 756 | |
| GeneFamily | WD repeat domain containing | 2.50e-03 | 262 | 65 | 5 | 362 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.56e-03 | 21 | 65 | 2 | 813 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP | 4.23e-06 | 199 | 86 | 7 | M8390 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 4.56e-06 | 74 | 86 | 5 | M4479 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 2.09e-05 | 352 | 86 | 8 | M17471 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 2.40e-05 | 260 | 86 | 7 | M1471 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 4.12e-05 | 283 | 86 | 7 | MM1157 | |
| Coexpression | GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP | 5.18e-05 | 200 | 86 | 6 | M8098 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN | 5.18e-05 | 200 | 86 | 6 | M7658 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 7.01e-05 | 130 | 86 | 5 | M17428 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-07 | 190 | 88 | 7 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.74e-07 | 163 | 88 | 6 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-06 | 186 | 88 | 6 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-06 | 188 | 88 | 6 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-06 | 190 | 88 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 2.26e-06 | 192 | 88 | 6 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.63e-06 | 197 | 88 | 6 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.86e-06 | 200 | 88 | 6 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.86e-06 | 200 | 88 | 6 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.86e-06 | 200 | 88 | 6 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.86e-06 | 200 | 88 | 6 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.86e-06 | 200 | 88 | 6 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.21e-05 | 170 | 88 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 178 | 88 | 5 | 6c1b5087581ca8cea976d89ea6f34088c8fc3668 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-05 | 179 | 88 | 5 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-05 | 180 | 88 | 5 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 181 | 88 | 5 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-05 | 184 | 88 | 5 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-05 | 184 | 88 | 5 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.31e-05 | 185 | 88 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-05 | 185 | 88 | 5 | 6e7fefdd65d30abaffb26b92b0d04e1630d262ad | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-05 | 185 | 88 | 5 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.40e-05 | 186 | 88 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 186 | 88 | 5 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 186 | 88 | 5 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-05 | 187 | 88 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 187 | 88 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 187 | 88 | 5 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 188 | 88 | 5 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.57e-05 | 188 | 88 | 5 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 188 | 88 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.66e-05 | 189 | 88 | 5 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.76e-05 | 190 | 88 | 5 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-05 | 190 | 88 | 5 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-05 | 190 | 88 | 5 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-05 | 190 | 88 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.85e-05 | 191 | 88 | 5 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Cycling_Myeloid-Mac|GI_small-bowel / Manually curated celltypes from each tissue | 3.85e-05 | 191 | 88 | 5 | c3944332c5226b0113f8aa9ac07837b755606c6c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.85e-05 | 191 | 88 | 5 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 192 | 88 | 5 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 192 | 88 | 5 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.95e-05 | 192 | 88 | 5 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 192 | 88 | 5 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.95e-05 | 192 | 88 | 5 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.95e-05 | 192 | 88 | 5 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-05 | 192 | 88 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-05 | 193 | 88 | 5 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-05 | 193 | 88 | 5 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-05 | 193 | 88 | 5 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-05 | 193 | 88 | 5 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-05 | 193 | 88 | 5 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-05 | 193 | 88 | 5 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.15e-05 | 194 | 88 | 5 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.15e-05 | 194 | 88 | 5 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.15e-05 | 194 | 88 | 5 | 8bfd7c5be518b81b17913139bcb3ebea01f48dd5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 194 | 88 | 5 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-05 | 194 | 88 | 5 | 8ac0b63c7a89e5ff78bbdd8dd1960aa2422a85f7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Mesenchymal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-05 | 194 | 88 | 5 | 4bafe26573cb2ff966f4a688c5769da598eea415 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 194 | 88 | 5 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.15e-05 | 194 | 88 | 5 | f0707601883b234ed477c7704ca9a88efaefc3fd | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.15e-05 | 194 | 88 | 5 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 194 | 88 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-05 | 194 | 88 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 195 | 88 | 5 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 195 | 88 | 5 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 195 | 88 | 5 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-05 | 196 | 88 | 5 | 53d1f9e9f009d1417a19ca6f9a83ecdf7776ef88 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 196 | 88 | 5 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-05 | 196 | 88 | 5 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-05 | 196 | 88 | 5 | 008e7593ab26988b957673f863bdd017516281ae | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 197 | 88 | 5 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 197 | 88 | 5 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.46e-05 | 197 | 88 | 5 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | COVID-19|World / Condition, Lineage and Cell class | 4.46e-05 | 197 | 88 | 5 | 228f641d79282cc3dc51b95a1f4b0cccfc200735 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.46e-05 | 197 | 88 | 5 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.46e-05 | 197 | 88 | 5 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.57e-05 | 198 | 88 | 5 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.57e-05 | 198 | 88 | 5 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.57e-05 | 198 | 88 | 5 | 9a89083280d4253f282300cdf1e61746d1f32407 | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 4.68e-05 | 199 | 88 | 5 | 09494953bc7fff63cf2763ea89fca7abb97c186f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.68e-05 | 199 | 88 | 5 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.68e-05 | 199 | 88 | 5 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 4.79e-05 | 200 | 88 | 5 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 4.79e-05 | 200 | 88 | 5 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|COVID-19 / Condition, Lineage and Cell class | 4.79e-05 | 200 | 88 | 5 | b0a50622d00335843efad86bc56a1e910019984b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.79e-05 | 200 | 88 | 5 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 126 | 88 | 4 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-04 | 126 | 88 | 4 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.25e-04 | 129 | 88 | 4 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 130 | 88 | 4 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Col15a1_Pde1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 130 | 88 | 4 | 56b9c3325e011f1dbaf9efc71bd6e1af4f96fda6 | |
| Disease | Cholestasis of pregnancy | 2.22e-04 | 8 | 84 | 2 | C0268318 | |
| Disease | rhinitis | 1.06e-03 | 17 | 84 | 2 | EFO_0008521 | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.06e-03 | 70 | 84 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.06e-03 | 70 | 84 | 3 | C3241937 | |
| Disease | coagulation factor measurement | 1.47e-03 | 20 | 84 | 2 | EFO_0004634 | |
| Disease | total blood protein measurement | 1.80e-03 | 449 | 84 | 6 | EFO_0004536 | |
| Disease | vital capacity | ZNF106 COL6A3 ANAPC10 UNC5B POLR2B NR5A2 GNB1 C3orf49 MYO16 MAF | 2.66e-03 | 1236 | 84 | 10 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQKVIGTNRKYFTNC | 51 | Q15582 | |
| EIKRYFCRAGVKSIQ | 281 | A0FGR8 | |
| YAQRRLKKRGIFCIS | 456 | Q4VNC1 | |
| QLTKFLYGFCKQSRR | 566 | P54840 | |
| LYGFCKQSRRQRIIQ | 571 | P54840 | |
| VRLYNTESQSFRKKC | 76 | Q9NZJ0 | |
| RKGFTYVFDLCQRQQ | 2906 | Q9Y485 | |
| VKIIQGCFYTKLERT | 2981 | Q8IZT6 | |
| ISKRNIQFSCKNIYR | 266 | P28907 | |
| RSSCINLYGKVVQKL | 1101 | Q68CQ1 | |
| VQLLYRASCFKVTKR | 246 | Q5TC82 | |
| QSKYCYSGIRRKTLV | 156 | P48382 | |
| RVIQYLTSNKCGKYV | 16 | O15381 | |
| FRRSITKNAVYKCKN | 161 | Q96RI1 | |
| TRSDKCKVVIQFFYR | 111 | Q6WBX8 | |
| CKVVIQFFYRHGIKR | 116 | Q6WBX8 | |
| ISRVSCLYNEKRIGQ | 131 | Q6NSI4 | |
| SRNAGKLICVRYFQT | 11 | P11182 | |
| CTFIQIFRYTGIRNK | 1091 | Q6IE37 | |
| YRVNGVKTRVEKLCQ | 796 | Q92619 | |
| VRALCYVISGQDQRK | 971 | Q66K74 | |
| LKNRGYAQSCRYKRV | 246 | Q9Y5Q3 | |
| TLKNRGYAQSCRFKR | 261 | Q8NHW3 | |
| LKNRGYAQSCRFKRV | 296 | O75444 | |
| SVKNCFIRGSVVRYV | 56 | Q9Y333 | |
| VVNYIAKKSFCRRAI | 546 | Q12866 | |
| QYRGTVSKTRKGVQC | 361 | Q2TV78 | |
| FCERKQQLTGARIYT | 561 | Q9Y6X6 | |
| KEYEKQVRNGRLFCT | 226 | Q9NQ38 | |
| KQQLRLKFATGRSCY | 136 | Q8IYT1 | |
| VVERKQTYGSCRKQR | 466 | P83111 | |
| CKRFGKAYNLRSVAV | 346 | Q86XP3 | |
| VVCGKRDSYIRKNVI | 421 | Q9NVH0 | |
| VRYICKQRQCKLSVA | 81 | Q8IVT5 | |
| TLKNRGYAQACRSKR | 166 | P54845 | |
| CSIYNLKTREGNVRV | 121 | Q9HAV0 | |
| YFQLCFKLGVKVRTA | 381 | Q92887 | |
| SGDQVQVRRCFEYKK | 151 | Q07075 | |
| ITNLVEKGRRKCDQY | 1826 | P23471 | |
| IQFRRKTTVKTLCIY | 66 | Q9UM13 | |
| YRKVGQCRRFQQLKK | 16 | Q96BT1 | |
| CSIYNLKTREGNVRV | 121 | P62873 | |
| SIAYGRCQKIGRQKL | 101 | A2RUU4 | |
| VQKLSRYGFNTERCQ | 186 | Q6P158 | |
| QRVILQAKCKGYFFV | 2756 | P12111 | |
| FYKLQGSVTVTCRNK | 481 | Q9BXR6 | |
| LYCNRGTVNSKLRKL | 296 | Q99615 | |
| QYKECFITNFISGRK | 561 | Q9P1V8 | |
| KTCFRGTVRLYNRQN | 866 | Q6ZTR5 | |
| NVVNTTKRDAGKYRC | 246 | P28827 | |
| CKGFFKRTVQNNKRY | 106 | O00482 | |
| IQRYFGTNSVICSKK | 56 | Q92665 | |
| GNRYIRCQKEVGKSF | 916 | Q9UPR3 | |
| KNRCLYVFGGQRSKT | 466 | Q9UL63 | |
| SVKYVYKLTIGCQRV | 131 | Q92546 | |
| FVTQLRYGKSRCKQV | 116 | Q9UL19 | |
| RARKNCSQIALFRKY | 211 | P0DUX0 | |
| RARKNCSQIALFRKY | 211 | P0DTA3 | |
| RARKNCSQIALFRKY | 211 | P0DUD1 | |
| LNQEGYKFCKIRVRS | 911 | P30876 | |
| YDKTCQFLSIGRRVK | 386 | Q9NWS8 | |
| EKVVQNVFQFRRKYC | 246 | Q8WVM0 | |
| LVKFVGNIYTLKCRF | 1586 | O95785 | |
| KNTKTGRVLYTCFQS | 161 | P46736 | |
| IYRKCGQTSKTQRLL | 991 | Q96P48 | |
| FLNILRQKSGRYVCV | 81 | Q2KHT3 | |
| RQKSGRYVCVQLLQT | 86 | Q2KHT3 | |
| AKRYNVGCTKRVGLF | 666 | Q8IXK0 | |
| VQRYVACRTEKQAKL | 266 | Q92911 | |
| RAYNRASCKFIVKVQ | 246 | O60687 | |
| RARKNCSQIALFRKY | 211 | P0DUX1 | |
| RARKNCSQIALFRKY | 211 | A0A494C0Z2 | |
| RARKNCSQIALFRKY | 211 | P0DUD3 | |
| RARKNCSQIALFRKY | 211 | P0DUD4 | |
| RARKNCSQIALFRKY | 211 | P0DUD2 | |
| NRIVQKGTQYSLCIF | 241 | Q9H5I1 | |
| YLCNGKRKKSQSQRF | 681 | Q12968 | |
| KYKSIISRRFFCIVG | 206 | Q86VZ5 | |
| IKRKVQQKRHCSTYQ | 201 | Q9GZR1 | |
| VRQLKVRNNTCKVYS | 131 | Q9NZM6 | |
| ANYTCVAKNIVAKRR | 221 | Q8IZJ1 | |
| NRVKKICEGFRASLY | 231 | Q93050 | |
| GRKFANRVVVTKYCD | 451 | P26368 | |
| VCRSKLSKYLQGVVF | 2286 | Q96JM2 | |
| DICGKVFNSKRYVAR | 246 | Q7L2R6 | |
| RARKNCSQIALFRKY | 211 | A0A494C191 | |
| ATEKFYTVLKCNNRR | 1126 | Q502W6 | |
| KRYKGNFLQSCVQLR | 1291 | Q5JPB2 | |
| QGSCRYFKERKNITN | 111 | Q12789 | |
| NLGKAVYSRVARICK | 246 | Q8NFY4 | |
| SYRKACVLQRQRKGS | 541 | Q5T4S7 | |
| GCFGSRSRKVKEQYQ | 646 | Q99959 | |
| KTVRVYNLVSRKCIG | 1551 | Q9H2Y7 | |
| NKCGKVFSRNSYLVQ | 236 | P51522 | |
| ALKRRFYVTTCVGKS | 91 | Q8NI36 | |
| QLVARIQATYKRCLG | 706 | Q8N1T3 |